[1] BAIDOUN F,ELSHIWY K,ELKERAIE Y,et al.Colorectal cancer epidemiology:recent trends and impact on outcomes[J].Curr Drug Targets,2021,22(9):998-1009.
[2] KIM JM,CHUNG E,CHO ES,et al.Impact of subcutaneous and visceral fat adiposity in patients with colorectal cancer[J].Clin Nutr,2021,40(11):5631-5638.
[3] TANIGUCHI Y,KUROKAWA Y,TAKAHASHI T,et al.Impacts of preoperative psoas muscle mass and visceral fat area on postoperative short- and long-term outcomes in patients with gastric cancer[J].World J Surg,2021,45(3):815-821.
[4] YANG T,WEI M,HE Y,et al.Impact of visceral obesity on outcomes of laparoscopic colorectal surgery:a meta-analysis[J].ANZ J Surg,2015,85(7-8):507-513.
[5] YOSHIZUMI T,NAKAMURA T,YAMANE M,et al.Abdominal fat:standardized technique for measurement at CT[J].Radiology,1999,211(1):283-286.
[6] LEE KH,KANG BK,AHN BK.Higher visceral fat area/subcutaneous fat area ratio measured by computed tomography is associated with recurrence and poor survival in patients with mid and low rectal cancers[J].Int J Colorectal Dis,2018,33(9):1303-1307.
[7] AMIN MB,GREENE FL,EDGE SB,et al.The Eighth Edition AJCC Cancer Staging Manual:Continuing to build a bridge from a population-based to a more "personalized" approach to cancer staging[J].CA Cancer J Clin,2017,67(2):93-99.
[8] GATTA A,VERARDO A,BOLOGNESI M.Hypoalbuminemia[J].Intern Emerg Med,2012,7(3):193-199.
[9] Chinese Nutrition Society Obesity Prevention and Control Section.Expert consensus on obesity prevention and treatment in China[J].Chin J Epidemiol,2022,43(5):609-626.
[10] HURWITZ EE,SIMON M,VINTA SR,et al.Adding examples to the ASA-physical status classification improves correct assignment to patients[J].Anesthesiology,2017,126(4):614-622.
[11] KATAYAMA H,KUROKAWA Y,NAKAMURA K,et al.Extended Clavien-Dindo classification of surgical complications:Japan Clinical Oncology Group postoperative complications criteria[J].Surg Today,2016,46(6):668-685.
[12] DE PERGOLA G,SILVESTRIS F.Obesity as a major risk factor for cancer[J].J Obes,2013,2013:11-19.
[13] COLLABORATORS GBDO,AFSHIN A,FOROUZANFAR MH,et al.Health effects of overweight and obesity in 195 countries over 25 years[J].N Engl J Med,2017,377(1):13-27.
[14] 田成功.内脏型肥胖[J].医师进修杂志,2004,27(8):6-9.
TIAN CG.Visceral obesity[J].Journal of Postgraduates of Medicine,2004,27(8):6-9.
[15] PARK JW,CHANG SY,LIM JS,et al.Impact of visceral fat on survival and metastasis of stage III colorectal cancer[J].Gut Liver,2022,16(1):53-61.
[16] LANDSKRON G,DE LA FUENTE M,THUWAJIT P,et al.Chronic inflammation and cytokines in the tumor microenvironment[J].J Immunol Res,2014,2014:149-185.
[17] HAMDY O,PORRAMATIKUL S,AL-OZAIRI E.Metabolic obesity:the paradox between visceral and subcutaneous fat[J].Curr Diabetes Rev,2006,2(4):367-373.
[18] HOHENBERGER W,WEBER K,MATZEL K,et al.Standardized surgery for colonic cancer:complete mesocolic excision and central ligation-technical notes and outcome[J].Colorectal Dis,2009,11(4):354-364.
[19] BERTELSEN CA,NEUENSCHWANDER AU,JANSEN JE,et al.Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery:a retrospective,population-based study[J].Lancet Oncol,2015,16(2):161-168.
[20] OUCHI N,PARKER JL,LUGUS JJ,et al.Adipokines in inflammation and metabolic disease[J].Nat Rev Immunol,2011,11(2):85-97.
[21] NAKAGAWA H,OHNO K,IKEDA S,et al.The effect of preoperative subcutaneous fat thickness on surgical site infection risk in patients undergoing colorectal surgery:results of a multisite,prospective cohort study[J].Ostomy Wound Manage,2016,62(8):14-20.